
What We're Reading: AstraZeneca's High-Profile Hire; Impact of Tax Penalty Ending; Rural Hospitals Get Creative
José Baselga, MD, who resigned his position as the chief medical officer at Memorial Sloan Kettering Cancer Center after failing to disclose millions of dollars in payments from drug companies, is joining AstraZeneca as its head of research and development in oncology; the end of the Affordable Care Act tax penalty on those without health insurance could roll back recent coverage gains for Hispanics, young people, the healthy, and the poor; rural hospitals are forming partnerships with home health agencies in order to survive.
Former Cancer Center Top Doctor Heading to AstraZeneca
José Baselga, MD, who resigned his position as the chief medical officer at Memorial Sloan Kettering Cancer Center after failing to disclose millions of dollars in payments from drug companies, is joining AstraZeneca as its head of research and development in oncology.
End of ACA Tax Penalty May End Coverage Gains for Some
The end of the Affordable Care Act (ACA) tax penalty on those without health insurance could roll back recent coverage gains for Hispanics, young people, the healthy, and the poor,
Rural Hospitals Forming Creative Partnerships With Home Health Agencies to Prevent Readmissions
Rural hospitals are forming partnerships with home health agencies in order to survive,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.